Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2022; 12(1): 94-105


Biochemical characterization and ecofriendly field application of the plant growth-promoting rhizobacterium Bacillus amyloliquefaciens MH046937 isolated from Salsola imbricata in Tur Sinai, Egypt

Warda E. Ashour, Moustafa M. Zohair, Ahmed A. El-Beih, Eman R. Hamed, Abeer A. Abd El Aty.




Abstract
Cited by 0 Articles

The root-colonizing biocontrol bacterium Bacillus amyloliquefaciens was used to fight some plant root pathogens in agriculture. Bacillus amyloliquefaciens MH046937 isolated from Salsola imbricata rhizospheres was evaluated for promoting the growth of an important food legume broad bean (Vicia faba L.) in Egypt. In vitro antagonistic effect tests showed that B. amyloliquefaciens was most effective against Sclerotium rolfsii followed by Alternaria alternata. The tested strain produced a substantial quantity of indole acetic acid equivalent to 32.9 ± 0.01 µg/ml and ammonia, also synthesized hydrogen cyanide at a moderate quantity, and solubilized phosphate. The bacterial fermentation proved the capability of B. amyloliquefaciens to produce the antifungal metabolite chitinase enzyme after 48 hours which contributes to its antagonistic activities. The major compound 1 was purified and identified as 5-hydroxymethylfurfural on the basis of the Nuclear Magnetic Resonance (NMR) measurements and the Electron Ionizatio (EI) mass spectroscopy. Greenhouse application indicated that B. amyloliquefaciens (T2 ) introduced a significant increase in germination percentage from 40% to 60% and reduced the disease incidence from 1.6 to 0.4 when compared with the control pots. The obtained results showed that B. amyloliquefaciens has both direct and indirect antagonism mechanisms against soil-borne fungi, depending on its multiple physiological traits and production of chitinase enzyme.

Key words: Rhizosphere bacteria, PGPR, Bacillus amyloliquefaciens MH046937, Characterization, biocontrol, Phytopathogens.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.